Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant is used to prevent cervical cancer.
How Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant Works Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant is a vaccine that helps develop immunity by initiating a mild infection. This type of infection does not cause illness, but it stimulates the body's immune system to produce antibodies that protect against future infections.
Common side effects of the Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant include joint pain, headache, vomiting, fever, dizziness, nausea, diarrhea, injection site reactions (pain, swelling, redness), upper respiratory tract infection, general discomfort, sleepiness, nasal congestion, joint inflammation, and arthropathy.